88 related articles for article (PubMed ID: 5716399)
1. [Use of the "quadripositional" method in the treatment of hay fever during the season].
Kühn A
Allerg Asthma (Leipz); 1968 Apr; 14(1):66-8. PubMed ID: 5716399
[No Abstract] [Full Text] [Related]
2. [Specific desensitization in hay fever with commercial allergen extracts].
Lowewe G
Z Arztl Fortbild (Jena); 1966 Nov; 60(21):1211-3. PubMed ID: 5990876
[No Abstract] [Full Text] [Related]
3. Immunologic changes during specific treatment of the atopic state. 3. The immunologic response in the course of hyposensitization of hay fever patients with aqueous and alum - pyridine allergens.
Zavázal V; Stajner A
Acta Allergol; 1970 Apr; 25(1):18-24. PubMed ID: 5468237
[No Abstract] [Full Text] [Related]
4. [Treatment of hay fever].
Charpin J
Munch Med Wochenschr; 1970 Jun; 112(25):1188-93. PubMed ID: 5467934
[No Abstract] [Full Text] [Related]
5. Timothy pollen oral lyophilisate (standardised allergenic extract): new drug. Hay fever: 4 months' treatment for 4 days' relief?
Prescrire Int; 2008 Oct; 17(97):196. PubMed ID: 19536935
[No Abstract] [Full Text] [Related]
6. Treatment of allergic rhinitis with injections of allergenic extracts.
Med Lett Drugs Ther; 1973 Jun; 15(13):55-6. PubMed ID: 4576315
[No Abstract] [Full Text] [Related]
7. [Desensitization for those afflicted with hay fever. With 4 pricks hyposensitized to pollen].
MMW Fortschr Med; 2004 Mar; 146(11):58. PubMed ID: 15152778
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
[TBL] [Abstract][Full Text] [Related]
9. [Every tenth person has hay fever complaints. To whom do you advise hyposensitization?].
Ring J
MMW Fortschr Med; 2004 Sep; 146(37):12. PubMed ID: 15887694
[No Abstract] [Full Text] [Related]
10. A statistical review of double-blind studies on ragweed hay fever injection therapy.
Miller A
Ann Allergy; 1968 Jul; 26(7):339-47. PubMed ID: 4873806
[No Abstract] [Full Text] [Related]
11. [Desensibilizing treatment with microbial allergens].
Vershigora AE
Vrach Delo; 1969 Feb; 2():127-8. PubMed ID: 5779360
[No Abstract] [Full Text] [Related]
12. [Current therapy of hay fever].
Blamoutier J; Gouletquer J
Therapeutique; 1971 Feb; 47(2):167-9. PubMed ID: 4100969
[No Abstract] [Full Text] [Related]
13. [The treatment of hay-fever with depot corticosteroids (author's transl)].
Brenn H
Schweiz Rundsch Med Prax; 1977 Jan; 66(3):82-5. PubMed ID: 834719
[No Abstract] [Full Text] [Related]
14. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis.
Smith H; White P; Annila I; Poole J; Andre C; Frew A
J Allergy Clin Immunol; 2004 Oct; 114(4):831-7. PubMed ID: 15480323
[TBL] [Abstract][Full Text] [Related]
15. [Carbinoxamin and phenylephedrine (Rhinopront) in hay fever and nonseasonal allergic vasomotor rhinits].
Vondrová V; Vondra V; Ráthová E; Zelený M; Horák J
Cas Lek Cesk; 1972; 111(17):388-91. PubMed ID: 5024669
[No Abstract] [Full Text] [Related]
16. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
Hordijk GJ; Antvelink JB; Luwema RA
Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
[TBL] [Abstract][Full Text] [Related]
17. Treatment of seasonal allergic rhinitis using homeopathic preparation of common allergens in the southwest region of the US: a randomized, controlled clinical trial.
Kim LS; Riedlinger JE; Baldwin CM; Hilli L; Khalsa SV; Messer SA; Waters RF
Ann Pharmacother; 2005 Apr; 39(4):617-24. PubMed ID: 15741420
[TBL] [Abstract][Full Text] [Related]
18. Monoid sublingual immunotherapy.
Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hay fever with "Pollinex"].
Gniazdowski R
Otolaryngol Pol; 1978; 32(4):435-40. PubMed ID: 101956
[No Abstract] [Full Text] [Related]
20. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
Novembre E; Galli E; Landi F; Caffarelli C; Pifferi M; De Marco E; Burastero SE; Calori G; Benetti L; Bonazza P; Puccinelli P; Parmiani S; Bernardini R; Vierucci A
J Allergy Clin Immunol; 2004 Oct; 114(4):851-7. PubMed ID: 15480326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
